Randomised, double-blind, placebo-controlled, dose-ranging Phase II study of APD421 (amisulpride for IV injection) for the prevention of post-operative nausea and vomiting

Trial Profile

Randomised, double-blind, placebo-controlled, dose-ranging Phase II study of APD421 (amisulpride for IV injection) for the prevention of post-operative nausea and vomiting

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2013

At a glance

  • Drugs Amisulpride (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2012 Official Title amended as reported by European Clinical Trials Database record.
    • 28 May 2012 Primary endpoint 'Additional-treatment-required---rescue-medication' has been met according to an Acacia Pharma media release.
    • 28 May 2012 Primary endpoint 'Patients-with-nausea-and-vomiting' has been met, according to an Acacia Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top